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ABSTRACT 
 
  
E-LIQUID EXPOSURE CAUSES MULTIPLE CARDIOVASCULAR DEFECTS 
IN XENOPUS LAEVIS EMBRYOS 
By James E. Black III, B.S. 
A thesis submitted in partial fulfillment of the requirements for the degree of Master of 
Science in Biology at Virginia Commonwealth University. 
Virginia Commonwealth University, 2020 
Major Advisor: Amanda Dickinson, Ph.D. Associate Professor, Department of Biology  
 
Over the past several years vaping has become part of the cultural zeitgeist in the United 
States, with ECIG usage amongst those of reproductive age rising more and more. Due to a lack 
of regulation and research concerning their long term effects, public opinion trends toward the idea 
that they are somehow safer than their traditional counterparts. As cases of lung injury and ECIG 
related death are beginning to be reported more and more, it is clear that the misinformation about 
their safety is unfounded. Congenital heart defects (CHDs) are some of the most common birth 
defects currently in the United States. Increased risk of these conditions is known to be associated 
with traditional cigarette use, but information concerning the relationship between these conditions 
and electronic cigarette use is not readily available, highlighting an area in need of study. Xenopus 
laevis is an ideal model to evaluate the effects of ECIG exposure on cardiac, blood, and vasculature 
 ix 
development due to the familiarity with the X. laevis genome, their transparent nature, and their 
ex utero development all of which make alterations to development easy to evaluate throughout 
multiple stages.   
 In this study, I show that e-liquid exposure during development reduces ventricle size 
and heart rate as well as altering the expression of several cardiac, blood, and vasculature related 
genes in X. laevis embryos. Additionally, I suggest that these effects are not simply due to 
nicotine or frequent e-liquid additives propylene glycol and vegetable glycerin, but some other 
chemicals used in e-liquid. 
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1. Introduction 
 
 
The most common types of birth defects, affecting roughly 40,000 births each year in the 
United States, are a group of cardiovascular disorders referred to as congenital heart defects 
(CHDs) [22]. Roughly 2 million Americans between infancy and adulthood are currently living 
with CHDs. They remain the leading causes of perinatal mortality, with a current incidence rate 
of roughly 8% of live births globally. CHDs put a major financial and emotional strain on 
individuals living with them and their families, as they are synonymous with high out-of-pocket 
medical costs and a decrease in mental health [21]. One factor lending itself to high numbers of 
these congenital conditions is traditional cigarette use during pregnancy. Maternal prenatal 
cigarette use has a teratogenic effect on cardiovascular development, with children having a 10% 
relative increase in the risk of being born with a CHD, including septal and atrioventricular 
defects [23-24]. Over the last 12 years, a new method of smoking has continued to gain 
popularity in the United States as electronic cigarette (ECIG) use climbed over 78% from 2017 
to 2018. This accompanied a decrease in traditional cigarette use, attributed to the way ECIGs 
are marketed as well as the misinformation about their safety [6]. ECIG use is particularly 
dangerous as there is little regulation and a major gap in information concerning their long term 
effects. ECIGs pose a unique threat as they tout a long list of additives in addition to the nicotine 
found in traditional cigarettes. Due to the relationship between traditional cigarettes and the 
increased risk of CHDs, it is important to examine the relationship between ECIGs and these 
same heart conditions. It follows logically that there is a high potential for ECIGs to result in 
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similar heart defects as their traditional counterparts, made even more urgent because of the 
misconception that they are safer.   
 
1.1 Electronic cigarettes and their use 
 ECIGs are electronic devices that use an atomizer to aerosolize liquid products, 
often loaded as cartridges. These liquids contain nicotine, flavoring additives, and a humectant 
used to maintain moisture in the mixture [14]. Even though electronic cigarettes and vaping are 
still relatively new, the number of users is rapidly rising as it becomes normalized behavior. 
These devices are being hailed as a healthier, more socially acceptable method of smoking, and 
can be seen everywhere from designated outdoor smoking areas to school hallways, and 
restaurants. This prevalence is not entirely unexpected considering how these devices are 
marketed, and to whom they are marketed to. With a myriad of flavors made available ranging 
from tobacco and menthol to children's cereals and fruity cocktails, these substances seem to 
specifically be targeting adolescents, including women of reproductive age. This is a source of 
concern as studies show that roughly 15% of pregnant women are currently using ECIGs, with 
43-88% of those women considered dual users –using both electronic and traditional cigarettes. 
Almost all women who used ECIGs reported doing so because of a sense of perceived harm 
reduction and as an aid in cessation from traditional cigarettes. In actuality, ECIG use tends to 
renormalize traditional cigarettes and perpetuate nicotine addiction [3].  
While some of the chemicals that are in the e-liquids may be non-hazardous alone when 
aerosolized they become oxidized. This alters them in such a way that they become harmful, 
often converting into known carcinogens. ECIG vapor exposure has been shown to be cytotoxic 
to human stem cells, a fact that only further negates the wealth of public misinformation [11]. 
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1.2 Emerging dangers of vaping 
 Prior to 2016, there was no FDA involvement in e-cigarette regulation. For this 
reason, there was no requirement for warning labels on e-liquid packaging detailing the dangers 
of nicotine during pregnancy [25]. This, coupled with the fact that ECIGs have been marketed as 
being less harmful than traditional cigarettes, has painted a very misleading picture [26]. As of 
February 2020, there have been 68 deaths due to vaping-related illnesses. In addition, 2,807 
cases of ECIG related lung injury have been documented in the United States. These numbers 
continue to rise as more states are reporting [47]. In addition, there is mounting evidence from 
research studies in cell lines and animal models that vaping is not safe. For example, vaping or 
ECIG exposure has been shown to cause lung damage, increased angiogenesis, decreased heart 
rate and increased risk of cancer risk in rats and mice [15]. Deleterious effects on mucous 
membrane function and alteration of gene expression in numerous organs indicating increased 
cancer risk have also been observed [26]. From these studies, it is still not clear what components 
of e-liquids could be causing these problems. One possibility is the flavoring chemicals. For 
example, we know that the additive, diacetyl, causes bronchitis obliterans, commonly known as 
popcorn lung [1]. This chemical gives the vapor a "buttery" flavor when heated. This condition 
causes the bronchioles of the lungs to become irritated and can decrease their diameter causing 
complications and making it harder to breathe. This is the same flavoring that was once used in 
microwavable popcorn manufacturing, with many companies moving away from it after their 
employees presented large case numbers of bronchitis obliterans. Despite this, it continues to be 
used in some e-cigarette flavoring [2].  
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1.3 Dangers during development  
Several studies suggest that ECIGs could have detrimental effects both to the user as well 
as their unborn children. Embryonic cells may be even more sensitive to ECIG solutions than 
adult cells. For example, some ECIG liquids were shown to be cytotoxic to human embryonic 
stem cells while having no effect on adult pulmonary cells [43]. ECIG exposure caused low fetal 
weight in rats and mice, an indicator of other complications and perinatal morbidity [17].  
Electronic cigarette exposure has also been observed to have negative effects on neural 
development. Rats born to mothers exposed to aerosolized e-liquids had significant changes in 
the expression of genes in the frontal cortex. These observed alterations in the central nervous 
system transcriptome are associated with negative neurobiological outcomes in humans, 
including a decrease in cognition and memory function [19].  
Developmental concerns of ECIG exposure also extend to the cardiovascular system. 
Some aerosolized e-liquid vapor solutions were cytotoxic to fetal rat cardiomyoblast cell lines 
[16], and components of aerosolized e-liquids have been shown to negatively affect 
cardiovascular development in Zebrafish as well. Danio rerio exposed to aerosolized e-liquid 
solution presented high frequencies of heart abnormalities not observed in embryos exposed to 
nicotine alone [14, 18]. Embryos exposed to particulates showed severe anatomical and 
physiological abnormalities including mortality, delayed development, decreased oxygen 
consumption, decreased heart rate and hemorrhaging. Altered angiogenesis was also observed, 
with some blood vessels being completely absent [18]. One of the main components of ECIG 
solutions called propylene glycol produced detrimental effects in Zebrafish when embryos were 
exposed in vivo, including reduced growth, increased fluid in the pericardial sac, and 
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hyperactivity in larvae. When exposed to aerosolized propylene glycol, Zebrafish embryos had a 
“heart-string” phenotype in which the heart failed to loop properly [31].   
Previous studies have shown that e-liquid exposure resulted in a reduction of blood cells 
in the orofacial region of 100% of developing X. laevis embryos when compared to an 
unexposed control [1]. 
 
1.4 Transcriptome analysis of faces exposed to e-liquids 
An aerosolized mixture containing only nicotine, propylene glycol, and vegetable 
glycerin was shown to have a dose-dependent, statistically significant effect on craniofacial 
development in X. laevis, especially the shape of the orofacial region [1]. The inclusion of flavor 
additives to these basic aerosolized mixtures can have varying degrees of severity on craniofacial 
development, some of which can result in cleft palate. To help the lab determine how e-liquids 
could be affecting gene expression in the face, the transcriptomic changes were evaluated in 
microdissected faces using next-gen sequencing (RNAseq) (manuscript in prep). The top genes 
in the facial tissue that were decreased were all related to blood. One such gene, gata1, codes for 
an important transcription factor necessary for the normal production of blood cells; specifically 
erythrocytes and platelets through the process of hematopoiesis. gata1 knockout in mice leads to 
immature progenitor cells that are unable to properly differentiate and mature [4-5]. Mutations 
within the gata1 gene are associated with CHDs [27].  The results of this RNA-seq analysis have 
led to an investigation of the effect that e-liquid exposure has on blood supply in Xenopus laevis, 
through the processes of both erythropoiesis and angiogenesis, as well as the morphological 
development of the heart.  
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1.5 Benefits of Xenopus laevis as the developmental model 
The use of Xenopus laevis as the model in which this study will be conducted is 
innovative since it allows a variety of experiments to be done quickly and efficiently, ascribable 
to their rate of development. The current frog populations in the lab, coupled with the fact that 
these frogs can give up to several thousand eggs, 3-4 times a year translates to an almost "on-
demand" supply of embryos so that experiments can be repeated frequently and at very large 
sample sizes.  
The fact that they are ex utero enables me to observe and record important developmental 
stages in real-time, with very clear visual detail. As X. laevis develop, their skin is translucent 
enough to discern developing organs, not limited to the heart. This makes visualizing blood using 
both a light microscope as well as GFP-microscopy in transgenic lines easy. 
One common criticism of the use of these organisms relates to the fact that they are ex 
utero, unlike humans. This allows for a wide variety of experiments to be performed and real-
time observations to be made that would otherwise be impossible, or require more complex 
methodology. Another frequent misconception about the use of X. laevis is that observations in 
developmental dysfunction due to teratogens in these organisms are somehow different than 
those in humans, but this is not the case. There are numerous United States Government-funded 
studies specifically using X. laevis embryos as an indicator for possible toxic effects of 
pharmaceuticals or environmental teratogens on mammals. Several side-by-side studies have 
shown that certain teratogens have the same effects in both X. laevis and mice, strengthening our 
conviction that the data generated in this study will have the potential to be very relevant to 
public health [38-39]. Furthermore, as I am interested in prenatal effects of e-liquids wherein the 
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human embryo would be exposed via the placenta, X. laevis is once again an effective model as 
their embryonic dermal layer shares similar surface ion channels and transporters with the human 
placenta, helping to predict how e-liquid products would travel across these barriers [9, 10]. 
Finally, X. laevis, has been used in the past to model respiratory epithelium, as their skin contains 
cells capable of secreting mucus that act as a form of protection to the embryo. This is similar to 
how the ciliated epithelial cells of the human lungs act as a barrier to allow for the exchange of 
nutrients while protecting the body from pathogens. The similarity in structure and function 
between these two tissue types could give me stronger predictive capabilities about the behavior 
of ECIG products across the human lung. The ability to fertilize embryos in vitro allows me to 
generate an abundant amount of synchronized data between sibling embryos, granting a view of 
the differences in development between control and exposed embryos congruently. X. laevis are 
useful models for cardiac development because of their similarity in cardiogenesis in humans 
and might be even more useful that other model organisms for evaluating potential CHDs [27]. 
 
1.6 Heart development in X. laevis 
X. laevis has a three-chambered heart with two atria and a single ventricle. This single 
ventricle resembles the mammalian left ventricle and is responsible for pumping oxygenated 
blood into the systemic circulation. Although the amphibian heart is structurally different from 
mammalians, the basic developmental mechanisms that underlie the formation of this structure 
are similar. The development of the heart starts at Stage 10, between 9 and 11 hours post-
fertilization (hpf), during gastrulation. By stage 12 (~13 hpf) cardiac progenitor cells within the 
lateral plate mesoderm, located on both the left and right sides of the embryo, will begin to move 
toward the ventral midline at the anterior of the embryo. Once these cells meet at the midline by 
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stage 13 (~15 hpf) they fuse and soon after separate to give rise to the two heart fields. The first 
heart field forms the two atria and the ventricle of the heart. The second heart field gives rise to 
the outflow tract that is responsible for pumping blood into the systemic circulation. Between 
Stages 31 and 33 (~37-34 hrs pf) these cardiac progenitor cells join to form the primary heart 
tube [27].  
For these cardiac progenitor cells to become functional cardiomyocytes, they must 
undergo the process of differentiation. This begins when endoderm tissue starts secreting bone 
morphogenetic proteins (BMP). BMP receptors activate Smad proteins initiating the 
transcription of several heart-specific transcription factors such as GATA5, Nkx2, and Nkx5. 
These transcription factors then regulate the expression of cardiac-specific genes that enable 
cardiac cells to contract. Myocd is one such transcription factor that specifically regulates the 
differentiation of cardiac and smooth muscle, and cardiac gene expression [53]. Additionally, 
heart development relies on the inhibition of certain signaling pathways. For example, Dkk1 
inhibits Wnt/β-catenin signaling during specific early heart development stages. This inhibition 
ensures that proper differentiation takes place, as well as the controlled formation of important 
anatomical structures such as the outflow tract [52].  
At stage 33 the primary heart tube is a linear structure that begins extending posteriorly. 
The ventricular portion of the heart tube lies anteriorly to what will become the atria at this point 
in X. laevis development. Cardiac muscle contraction takes place at stage 35 (~44-50 hpf) [27]. 
This contraction encourages the linear structure to loop, forming a spiral structure with the 
presumptive atrium moving dorsally to the ventricular portion [45]. This movement continues 
until the atrial region is located medially while the ventricular portion moves to the right and is 
displaced laterally eventually descending, residing in the pericardial cavity. This looping 
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continues until stage 40 when the atrial region of the heart tube comes to rest directly dorsal to 
the ventricular region. This process is regulated by the Xnr1 gene that controls the expression of 
BMP, which is expressed during the looping process solely on the left side of the linear heart 
tube. This gives the entire process conserved directionality and ensures proper looping to 
maintain function and form [46]. Finally, between stages 40-46 (~66-106 hrs pf) the looped heart 
tube begins to form individual chambers and the atria are finally separated into two independent 
structures [27] (Table 1 A.) 
 
1.7 Vasculature development in X. laevis 
Vasculogenesis begins with the differentiation of ventral and lateral plate mesoderm into 
hemangioblasts regulated by FGF signals. This occurs when FGF2 binds its receptor causing 
mesodermal cells to begin transcribing VEGFR2/Flk1 receptors during neurulation around stage 
15. When VEGF in the cell environment binds these receptors, it promotes the formation of 
hemangioblasts, which become subdivided into the primitive blood islands. These blood islands 
go on to form the blood as well as endothelial cells, which will become the vasculature. During 
stages 27-32 of X. laevis development (31 - 40 hpf), VEGF binds its receptor (Flk1) on 
presumptive endothelial cells and this signaling pathway regulates their migration and 
differentiation into strands of cells. Next, VEGF stimulates the hemangioblasts to begin 
transcribing Flt1 receptors which in turn will bind VEGF leading to the promotion of tube 
formation. Tubes are ultimately formed from these strands of endothelial cells by the coalescence 
of many vacuoles into a single lumen. These newly formed tubes assemble into a primitive 
network or plexus and by stage 35 in X. laevis, circulation begins. 
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Next, this primary network is remodeled through angiogenesis where vessels use 
“filopodia” on Tip cells to reach out and connect with one another, originating and extending 
from previously established vessels [61].  This process is regulated by PDGF and TGF-β 
signaling, ensuring that the Tip cells can properly navigate their environment and ensure that 
vessels fuse with their complement. This is also regulated by Delta notch signaling, with higher 
Notch stimulation apparent in arteries compared to lower levels in veins.  
By stage 46 much of the remodeling is complete and the principal blood vessels are 
formed [64-65] (Table 1 C). 
 
1.8 Blood development in X. laevis 
The early embryonic blood ultimately forms from the blood islands arising from the 
ventral mesoderm, before transitioning to the dorsal lateral plate (DLP) and dorsal aorta as 
development continues. Unlike the blood islands, the DLP contributes solely to the adult 
hematopoietic lineages [68].  
Precursors to both immature and adult blood cells can first be seen at stage 6, at the 32-
cell embryo stage. Cells destined to become the ventral blood island (VBI) begin collecting 
together and migrating ventrally during gastrulation between stages 10-14 (9 - 16 hpf). After 
being exposed to BMP the blood island precursors begin to express hematopoietic genes causing 
these tissues to begin differentiating into endothelial cells as well as the stem cells that will 
eventually give rise to blood cells between stages 14-18 (16 - 20 hpf) [69]. These hematopoietic 
stem cells will continue to differentiate in response to a great number of erythroid transcription 
factors like Runx1, which works to convert endothelial cells into blood stem cells. Runx1 
expression is regulated by an intricate network of erythroid transcription factors such as SCL, 
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that works to ensure primitive blood cells are not converted to cardiac muscle, as well as GATA2 
and Fli1. Runx1 is also important in the formation of megakaryocytes that will eventually mature 
to become platelets through its coexpression and interaction with GATA1 [66-68]. GATA1 is a 
transcription factor that is necessary for the normal production and maintenance of both RBCs 
and platelets. GATA1 expression, like GATA2 and SCL, is first triggered by BMP signaling. 
GATA1 does not work alone, as it must first complex with its cofactor FOG1 to function 
properly. Knockdown experiments of either GATA1 or FOG1 were shown to have lethal effects 
due to the lack of formation of megakaryocytes and platelets [66]. GATA1 also works to ensure 
the survival of red blood cells by regulating the expression of genes that alter the cell cycle to 
avoid apoptosis. One example is the stimulation of Bcl-Xl, an antiapoptotic protein [67]. 
 The VBI finishes forming by stage 30 and is the primary site of hematopoiesis between 
stages 26-40. By stage 35 though the blood is still considered to be “primitive” circulation 
begins. Meanwhile, cells from the DLP have begun to migrate toward the midline, and after 
expressing the Flk1 receptor will form the dorsal aorta (DA) by stage 38 (~53 hpf) [70]. After 
stage 40 the VBI no longer exists, and the hematopoietic clusters within the DA become the site 
of blood development and the establishment of the adult lineages [69]. 
 Blood cells mature over a period of 26 days, and by stage 52, adult RBCs begin to 
appear in circulation. Immature erythrocytes continue to be replaced by mature erythrocytes 
throughout metamorphosis. At stage 60, half of the primitive blood cells will have been replaced 
by mature RBCs, but the conversion process will continue well past metamorphosis. Sixth 
months after X. laevis adult’s complete metamorphosis, the primitive erythrocytes have all been 
replaced by mature, functioning RBCs as the source for production changes [44].  As X. laevis 
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mature through metamorphosis the liver becomes the primary location for hematopoiesis, and 
then through adulthood that site becomes bone marrow [29-30] (Table 1 B). 
 
Based on preliminary evidence in X. laevis and zebrafish, I propose that e-liquid exposure 
could affect cardiovascular development. Here in this thesis, I show that exposure to a popular 
flavored e-liquid causes abnormality in heart morphology and function, as well as blood 
distribution, and vascular arrangements. The effects on heart development may not be due 
merely to nicotine, or inert carriers since these alone had little effect on heart development. 
Further, both neat and aerosolized e-liquid preparations can result in similar effects on heart size 
suggesting that heating the e-liquids may not alter them to create any dangerous chemicals.  
Finally, e-liquid exposure can alter the expression of some cardiovascular regulatory genes.  
Thus, I have begun to uncover mechanisms to explain why these defects occur. 
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2. Methods and Materials 
2.1 Animals 
Using protocols described in Sive’s laboratory manual, an adult female frog was injected 
with human chorionic gonadotropin (HCG) to induce egg laying. Eggs were then collected, 
fertilized and cultured using standard protocols [83]. Tadpoles were staged according to 
Niewekoop and Faber [84]. All experiments were performed following the approved IACUC 
protocol AD20261. 
 
2.2 E-liquid exposures in Xenopus laevis embryos 
Beginning at stage 4, embryos were cleaned and sorted to remove any unfertilized eggs 
as well as any embryos failing to divide. When embryos reached staged 20-24, they were 
pipetted using a large-bore plastic transfer pipette into sterile Petri dishes or culture plates 
containing 0.1X Modified Barth’s Saline (MBS). Experimental solutions were added to the 
solution and the mixtures containing embryos were gently swirled.  Chemical exposures 
consisted of neat Revel (1:1000, Cloud Company), aerosolized Revel (1:100, [1]), nicotine 
(10mg/ml), and aerosolized nicotine +PG+VG (1:100, [1]). Embryos were then incubated at 
23°C. In some experiments, embryos were removed from exposure at stage 30 and processed for 
PCR (see section 2.8). Alternatively, embryos were exposed until stage 40. After this, they were 
removed and placed into 0.1xMBS until stages 45 - 46.  At this time X. laevis embryos were 
processed for heart morphology (section 2.6 - 2.7), heart rate (section 2.5), blood and vascular 
assessments as described below (section 2.3 - 2.4) (Fig. 1.) 
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2.3 Histological blood label (o-Dianisidine staining)  
The staining solution consisted of 120mL dH2O, 80mL EtOH (DeconLabs: V1016), 
1.3mL 30% Hydrogen Peroxide (MilliporeSigma: HX0635-3), 0.12g Sodium Acetate (Sigma 
Aldrich: S2889-250G), and 0.16 o-Dianisidine (Sigma Aldrich: D9143), referred to as "O-
dianisidine solution." The solution works as a marker for blood development as the hemoglobin 
present in fully mature red blood cells catalyzes the Hydrogen Peroxide to begin oxidizing o-
Dianisidine to produce a dark red stain in any hemoglobin positive cells. After the standardized 
Revel exposure (Fig 1) embryos were fixed for 20 minutes in 4% paraformaldehyde (PFA). They 
were then placed in 1.5mL Eppendorf tubes and washed in phosphate-buffered saline solution 
with Tween (PBT) 3 times for five minutes each. All of the PBT was removed and replaced by 
1.5mL of the O-Dianisidine solution to ensure the embryos were covered. The solution needs to 
be mixed at room temperature for at least 20 minutes before adding. The effect of the solution 
warming in the Eppendorf tube causes them to burst, leading to possible damage to the samples 
and inconsistent staining. The tubes were wrapped in foil and left mixing for 40 minutes. 
Embryos were washed in PBT twice for two minutes each, and then all PBT should be removed. 
The embryos were incubated in 4% PFA for 24 hours at 4°C while still covered in foil. Embryos 
were washed again in PBT, 3 times for 5 minutes each, and then 70% glycerol (Biotech: 
GB0232) was added and embryos were imaged on white clay (Zeiss Discovery V8 Axiocam 503 
Color using Zen software.)  
 
2.4 Transgenic X. laevis experiments  
Transgenic X. laevis used to visualize vascular (XB-LINE-916, Flk1-GFP, FLK-1; 
Xla.Tg(flk1:GFP)1Mead) and blood (XB-LINE-1216, Xla.Tg(gata1:GFP)Mead) development 
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were ordered from Marine Biological Laboratory. The anterior of the embryos were imaged 
using Zen software from a ventral and lateral view using 1% agarose as a base (Excelitas 
Technologies: X-Cite Series 120 Q, Zeiss: Discovery V8 SteREO, Carl Zeiss Microimaging 
GmbH.) 
 
2.5 Heart rate  
Light microscopy was used to image and record heart rates of both Revel exposed and 
control embryos (Zeiss Discovery V8 Axiocam 503 Color using Zen software.) First, the 
standardized Revel exposure protocol was used to treat embryos (Fig 1.) The embryos were 
washed in 0.1xMBS and allowed to progress to stage 45. 500 µM Tricaine (Western Chemical: 
051819) in 0.1xMBS was set out for twenty minutes and allowed to reach room temperature. 
Working in groups of five (five exposed and five control) embryos were then to be placed into 
the 0.1xMBS Tricaine solution for twenty minutes to acclimate to the dish temperature. Heart 
rates, measured in beats per minute, were assessed by counting the number of beats for 30 
seconds and then multiplying by two. The mean heart rate for each of the experimental 
conditions is assessed. To control for any possible differences in stage, time, or temperature the 
experimental mean was divided by the control mean to establish a relative change in heart rate. 
 
2.6 Light microscopy 
 After experimental embryos are exposed to the Revel solution using the standardized 
protocol (Fig 1), the embryos were washed in 0.1xMBS and allowed to mature to stage 45. At 
stage 45 embryos were fixed in 4% PFA and imaged using a stereoscope (Zeiss Discovery V8 
Axiocam 503 Color using Zen software.) 
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2.7 Anti-Troponin T-C (CT3) staining 
After experimental embryos are exposed to the Revel solution using the standardized 
protocol (Fig 1),  embryos were washed in 0.1xMBS and allowed to reach stage 45, at which 
point they were fixed in 4% PFA overnight at 4°C. Embryos were then placed into 1.5mL 
Eppendorf tubes, limiting each tube to 10 embryos. The fixative was removed and replaced with 
PBT. Embryos were left in fix for 24 hours, no more and no less, as any variance, limits the 
efficacy of the stain or causes them to deteriorate respectively. The embryos were then washed in 
PBT three times for one hour. During the final wash, a primary antibody solution consisting of 
20µl of CT3 antibody (Developmental Studies Hybridoma Bank: AB_528495) in 500µl of PBT 
was prepared for each tube containing embryos. After the final wash, all of the PBT was 
removed from the tubes and then 0.5ml of the primary antibody solution was added. The 
embryos were left in the primary antibody solution at 4°C for seven days. After seven days, the 
primary antibody solution was removed and replaced with PBT. Three washes of one hour were 
performed. During the final wash, a 1:500 secondary antibody solution was prepared by adding 
2µl of green fluorescent secondary antibody Alexa 488 goat anti-mouse (ThermoFisher: A-
11001) in 1mL of PBT. After the final wash, all of the PBT was removed and replaced with 
0.5ml  of the secondary antibody solution. At this point, the reaction is highly light-sensitive, so 
tubes were promptly covered with foil. The embryos were kept in the secondary antibody 
solution at 4°C for six days. Next, the secondary antibody solution was removed,  and the 
embryos were washed three times in PBT for at least one hour each. The embryos were 
equilibrated in series in 50% glycerol until the embryos sank to the bottom of the Eppendorf 
tube. Next, the 50% glycerol was removed, and 75% glycerol was added. Once again time was 
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taken to allow the embryos to sink. Once the embryos sank, they were imaged in 75% glycerol 
using 1% agarose as a base (Excelitas Technologies: X-Cite Series 120 Q, Zeiss: Discovery V8 
SteREO, Carl Zeiss Microimaging GmbH.)  
 
2.8 RT-PCR experiments 
At stage 20-24, X. laevis embryos were randomly split into two groups and placed into 
25mL of 0.1xMBS. The experimental groups were exposed by adding 25µl of neat Revel 
solution and then incubated at 23°C until stage 30 for early heart markers and early gata1 
experiments, or stage 40 for later stage gata1 experiments. They were then washed in 0.1xMBS 
and placed into 800µl of Trizol (Ambion Fisher: 15596026) that was resting in ice. The embryos 
were incubated for 10 minutes in the lab at room temperature (24°C) and then stored in a -80°C 
freezer overnight for roughly 24 hours. The next day the tissue was thawed on ice and then 
“homogenized” using both pestles and a Fisherbrand™ Mini Vortex Mixer (Fisher Scientific: 
14-955-151) to begin the RNA extraction process. Next, the resulting mixture was centrifuged at 
max speed for 10 minutes, and roughly 800µl of the supernatant was placed into a new 1.5mL 
Eppendorf tube, while the remaining insoluble material was discarded. Using proper PPE 
(goggles, gloves, and a lab coat), 200µl of Chloroform (Fisher Scientific: C606SK-1) was added 
in the fume hood to the tube, vortexed for 15 seconds, and then left to incubate at room 
temperature for 3 minutes. Tubes were then placed into a Sorvall™ Legend™ Micro 21R 
Microcentrifuge (Thermo Fisher Scientific: 75002447) and centrifuged for 30 minutes at 12000g 
speed and 4°C. Next tubes were removed carefully and 200µl of the aqueous phase containing 
RNA was removed and placed into a new tube, while the rest was discarded. 500µl of isopropyl 
alcohol was added to the solution, incubated for 10 minutes, and then centrifuged again for 20 
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minutes at 12000g speed and 4°C. The resulting supernatant was then discarded, 1 ml of 75% 
Ethanol was added, and the mixture was centrifuged at 7500g speed and 4°C. Again, the 
supernatant was discarded, and the remaining material was centrifuged for 10 seconds. Any 
additional liquid was removed, and the resulting pellet was left to dry. 50µl of ultrapure distilled 
water was added to the pellet, followed by 25µl of a LiCl Precipitation Solution  (Thermo Fisher 
Scientific: AM9480) and then left to incubate overnight at -20°C. The next morning samples 
were defrosted on ice and then centrifuged at max speed for 30 minutes at 4°C. The supernatant 
was discarded and then 1ml of 70% ethanol was added before centrifuging again for 30 minutes 
at max speed and 4°C. The supernatant was discarded, and the tube was respun for 10 seconds. 
The resulting pellet was set to dry for 5 minutes before being resuspended in 30µl of Nuclease-
Free Water (Thermo Fisher: AM9938).  Next, resulting RNA was tested for concentration and 
purity before being used in RT-PCR.  
In order to quantify expression levels of early cardiac genes and gata1 with ef1-α as a 
housekeeping gene (BioMolecular Systems micPCR, using micPCR v2.6.5 software) a Luna® 
Universal One-Step RT-qPCR Kit (New England BioLabs: E3005S) was used in which the 
generated RNA can be used directly for RT-qPCR experiments. Materials were thawed at room 
temperature and then placed on ice. Master mixes were created using 10µl of Luna Universal 
One-Step Reaction Mix (2X), 1µl of  Luna WarmStart® RT Enzyme Mix (20X),  0.8µl of 10µM 
forward primer and 0.8µl of 10µM reverse primer, and 6.4 µl of Nuclease-Free water. After 19µl 
of this master mix was placed into the appropriate qPCR tube 1µl of 10ng/µl Template RNA was 
added. Samples were placed into the micPCR machine and the following protocol was used. A 
single reverse transcriptase phase of 10 minutes at 55°C, a single initial denaturation cycle at 
95°C, followed by 45 cycles of a Denaturation stage of 10 seconds at 95°C, an extension phase 
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of 30 seconds at 60°C, followed by a single melt curve cycle between 60°C and 95°C.  Results 
were gathered using the micPCR v2.6.5 software. Primers used were as follows: myocd, 5′-GCC 
CAA AGC AAA TTA CAA GAA-3′ (forward) and 5′-GGA AGT CGG TGT TGA AGA TAC-
3’ (reverse) [53]; dkk1,  5′-TCC CAG AAG AAC CAC ACT GAC-3′ (forward) and 5′-GGT 
GCA CAC CTG ACC TTC TT-3′ (reverse); tnni3 5′-CTG CCG ACG CCA TGA TG-3′ 
(forward) and 5′-GTT TGA GAC TGG CCC GTA GGT-3’ (reverse) [52]. 
Stage 40 gata1 PCR experimental embryos were exposed to Revel solution according to 
the standard exposure protocol (Fig 1), removed at stage 40, and were then placed into 0.1xMBS 
and a few drops of Tricaine (Western Chemical: 051819) was added. 30 heads from both the 
control and exposed groups were dissected and collected in 800µl of Trizol (Ambion Fisher: 
15596026), taking care to avoid including the heart and anything posterior to it. RNA was 
generated using the same protocol described above. cDNA was then synthesized using a 
Sensifast™ cDNA Synthesis Kit (Bioline Meridian Bioscience: Bio-65054). A master mix was 
made for control and Revel treated RNA separately consisting of 4µl of a SensiFast 5x 
TransAmp Buffer, 1µl of Reverse Transcriptase, 1µg of RNA, and enough Nuclease-Free water 
to bring the total volume of each tube to 20µl. Tubes were placed into a thermocycler set to the 
following protocol: an annealing step at 25 °C for 10 minutes, a reverse transcription step at 42 
°C for 15 minutes, an inactivation step at 85 °C for 5 minutes, and finally a hold step at 4 °C. 
The resulting cDNA was then used in RT-PCR. RT-PCR was performed using a  SensiFAST™ 
SYBR® No-ROX Kit (Bioline Meridian Bioscience: BIO-98005) to quantify expression levels 
of gata1 using ef1-α as a housekeeping gene (BioMolecular Systems micPCR, using micPCR 
v2.6.5 software.) Primers were suspended in Nuclease-Free water from 100µM stock solutions to 
10µM aliquots of 25µl. Master mixes were made using 10µl of 2x SensiFAST™ SYBR® No-
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ROX Mix, 1µl of the template cDNA, and 8µl of dH2O. Primer mixes were made using  0.5µl of 
10µM forward primer and 0.5µl of 10µM reverse primer. Once these were created, 19µl of the 
Master mix was added to a qPCR tube, followed by 1µl of the appropriate primer mix. Results 
were gathered using the micPCR v2.6.5 software. 
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3. Results 
 
3.1 Revel exposure causes alterations in heart morphology  
To assess heart morphology the heart was imaged at stage 45 when the looping process is 
complete and septation has occurred in the atria, resulting in the three individual chambers of the 
heart being formed. Basic light microscopy, as well as immunofluorescence using an antibody 
that binds to a heart-specific muscle protein, cardiac troponin (Tnni3), was used. 
In Revel exposed embryos, altered heart morphology was observed using both 
techniques.  Specifically, the ventricles were smaller, and the position of the ventricle and 
outflow tract appeared different than in controls. (Fig 2 A-H.) Outflow tracts in the Revel 
exposed embryos lacked the distinct curvature observed in all controls often making the hearts 
appear longer (Fig 2 B, D) 
To quantify differences in heart size, measurements of ventricle diameter, from anterior 
to posterior in a ventral view were recorded(Fig 2 A, C.) A statistically significant difference 
was found between the embryo ventricle diameters of exposed (N=30) compared to control 
(N=41) embryos (student t-test, p-value = 0.009) (Fig 2 J.) To further compare the changes in 
heart size between the two groups a categorical analysis where the ventricle diameter of each 
embryo was equally categorized into large, medium, small, and extra small was created. Each 
category was then visualized on a stacked bar graph in an attempt to better see trends in the data. 
Results indicate that 37% of the Revel exposed embryo ventricle measurements fell into the 
“small” range (230.36 µm to 285.54 µm), compared to only 11% of the control. None of the 
control embryos fell into the “extra small” range (175.19 µm to 230.35 µm), while 16% of Revel 
exposed embryos did (Fig 2 I.) Additional differences in morphology were apparent as the Revel 
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exposed embryo hearts tended to appear “longer,” and more random in orientation, perhaps due 
to the disrupted looping patterns.  
Together, the results indicate that Revel exposure causes defects in the morphology of the 
heart, specifically in the size of the ventricle. 
 
3.2 Revel exposure reduces heart rate  
To assess the function of the heart, I used light microscopy to measure heart rates of both 
Revel exposed and control embryos. A statistically significant reduction in heart rate was 
observed in Revel exposed embryos (N=60) when compared to the unexposed controls (N=60), 
with a relative decrease of 14% (3 biological replicates, Mann-Whitney Rank Sum, P = <0.001) 
(Fig 2 K.) A categorized analysis and stacked bar graph revealed that of the Revel exposed 
embryos, 42% were shown to have a decreased heart rate in a range (110.4-131.6 bpm) that fell 
below any of the control specimens (Fig 2 L.) Additionally, ventricle contraction in Revel 
exposed embryos at times appeared sporadic and less uniform than the controls. 
These results indicate that in addition to morphological malformations, Revel exposure 
also causes a reduction in heart rate.  
 
3.3 Exposure to neat and aerosolized e-liquid solution preparations have similar effects 
Next, to determine whether the process of aerosolization alters e-liquids in such a way 
that could affect the heart differently, sibling embryos were exposed to both aerosolized and neat 
Revel. Preliminary experiments in the lab were performed to test various concentrations of each 
preparation and it was determined that 1:100 dilution of aerosolized had almost identical effects 
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as a 1:1000 dilution of neat Revel [1].  This is consistent with calculations of nicotine 
concentrations in the aerosolized Revel preps.  
Whole embryos exposed to neat and aerosolized Revel each showed similar reductions in 
overall length and a curved body axis when compared to controls. Also, similar levels of edema 
in the anterior portion of the embryo, as well as gut abnormalities, were observed in embryos 
exposed to both preparations, and absent in controls. In both preparations, e-liquid exposure led 
to a phenotype in which the eyes were located closer together when viewing dorsally. Similar 
lens defects in the eye were also observed in both groups, but absent in controls (Fig 3 A-C.)  
To determine if the heart ventricle size was affected in the same way by both 
preparations, ventricle sizes were measured from a ventral view as mentioned above. There was 
an apparent reduction in the ventricle size when visualized using light microscopy (Fig 3 D-F.) 
To visualize the relationship between ventricle size between the two groups I performed a 
categorial analysis and created a stacked bar graph with a small sample of embryos (n=36, 1 
replicate). 75% of control embryos fell into a range of 294.67µm and 346.00µm, compared to 
only 23% of aerosolized, and 14% of neat e-liquid exposed embryos. Roughly 70% of both the 
aerosolized and neat exposed embryos fell into a range of 242.33µm and 293.67µm, compared to 
only 25% of the control. Finally, 8% of the aerosolized Revel and 14% of the neat Revel exposed 
embryos fell into the smallest range of 190µm and 241.33µm, while none of the controls were 
found to be that small (Fig 3 G.)  
Together, these results suggest that the effects of e-liquid exposure are similar regardless 
of the preparation. Most importantly, concerning the observed decreases in heart size and heart 
rate in this study, the effects of the teratogenic chemicals observed do not seem to be different 
when the e-liquid is aerosolized.  
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3.4 Exposure to neither neat nicotine nor a solution of aerosolized nicotine, propylene glycol, 
and vegetable glycerin reduced ventricle size or heart rate 
To determine whether the observed changes in heart morphology and function recorded 
were due to additives in the Revel flavorings or due solely to nicotine and other common carrier 
fluids in e-liquids. To assess this, sibling embryos were exposed to a neat preparation of nicotine 
and an aerosolized mixture of nicotine, propylene glycol, and vegetable glycerin (referred to as 
nicotine+PG+VG.) Light microscopy and immunofluorescence using an antibody that binds to 
Troponin, a cardiac-specific muscle protein, were used to evaluate heart rate and ventricle size in 
these embryos compared to controls.  
No significant difference was found in ventricle diameters between the embryos exposed 
to neat nicotine, nicotine+PG+VG, or control embryos (Kruskal-Wallis One Way Analysis of 
Variance on Ranks, p-value = 0.418) (Fig 4 B.) Ventral images of control, nicotine, and 
nicotine+PG+VG exposed embryos showed no observable difference in ventricle size, shape, or 
orientation (Fig 4 C-E.) 
Similarly, no significant difference was observed in the heart rate between neat nicotine, 
nicotine+PG+VG, and control embryos (Kruskal-Wallis One Way Analysis of Variance on 
Ranks, p-value = 0.533) (Fig 4 A.)  
These results indicate that neither neat nicotine nor nicotine plus the common e-liquid 
additives Propylene Glycol and Vegetable Glycerin had significant effects on heart morphology 
or heart rate. 
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3.5 Revel exposure alters vascular organization  
To assess any alteration in developing vasculature in embryos exposed to Revel I utilized 
a transgenic line in which GFP is driven by the flk1 promoter. flk1 is expressed in the developing 
vasculature and therefore allows visualization of GFP in the blood vessels. 
Unexposed control embryos showed a consistent and mostly symmetrical vascular 
network in the orofacial region across 100% of specimen. While there was some observable 
vasculature supplying the face in experimental embryos, what resulted was a spectrum of 
phenotypes. Only 20% of embryos appeared to have similar vascular networks and branching 
patterns when compared to controls. The remaining 80% had varying numbers of vessels present, 
and the patterns of vascular branching were less organized in mild phenotypes. In some more 
extreme phenotypes, large parts of the network seemed to be absent altogether.  Edema was 
noted in the anterior portion of 80% of exposed embryos. On the whole, experimental embryos 
were shown to be of a reduced size when compared to controls (Fig 5 I-L.) 
These results suggest that e-liquid exposure does, in fact, alter vasculature development. 
 
3.6 Revel exposure alters the localization of blood in embryos 
 
3.6a) O-Dianisidine staining 
To assess the effect that e-liquid had on the location of blood in the orofacial region of 
exposed embryos, I used light microscopy and O-Dianisidine staining to detect hemoglobin [42].  
100% of control embryos had vivid networks of O-Dianisidine labeling in the face, and 
from most ventral and dorsal views there was extensive vascular branching to other areas around 
the craniofacial region (Fig 5 A.) By contrast, 87% of Revel exposed embryos had little or no O-
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Dianisidine labeling in the head accompanied by excess labeling near the heart and digestive 
system (n=80, 4 biological replicates) (Fig 5 B-C.) The remaining 13% of Revel exposed 
embryos that had staining were still distinct from the control group. In these embryos, a random 
scattering of blood cells with no real consistent pattern in location was observed (Fig 5 D). These 
embryos showed similar signs of blood pooling around the gut or tail.  
These results suggest that e-liquid exposure alters the amount of hemoglobin containing 
red blood cells present in the orofacial region of developing embryos. 
 
3.6b) GATA1 Transgenic blood marker 
To confirm that there was indeed a difference in blood localization in embryos exposed to 
Revel I next used another technique to visualize blood cells. Here I utilized a GATA1 transgenic 
line that expresses GFP in circulating blood cells. Individual blood cells were imaged as they 
moved throughout the embryo in real-time. Conserved networks of moving fluorescing cells 
marking the presence of Gata1 expression was observed in 100% of control embryos (Fig 5 E.) 
However, while exposed embryos did show varying amounts of blood cells anterior to the gut, 
only 61% of them had similar levels to those of the control. Further, of that 61% of exposed 
embryos, the observed branching patterns lit by Gata1 in blood cells were not as conserved and 
appeared more random when compared to controls (Fig 5 H.) 
The remaining 39% appeared to have far lower numbers of blood cells in the orofacial 
region, with many of the conserved branching patterns of the controls completely absent (Fig 5 
F, G.) Using RT-qPCR, the micro-dissected faces of Revel exposed embryos at stage 40 showed 
a reduction in the level of gata1 expression in the orofacial region, with a fold change of 0.58 
(student t-test, p-value = 9.91 x 10-6) (Fig 5 M.) 
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3.7 Revel exposure alters the expression of regulatory genes prior to the start of circulation 
 
3.7a) Blood regulator GATA1 
One could hypothesize that the changes in blood distribution could simply be due to a 
reduction in heart function and/or vascular malformation. On the other hand, the observed 
changes in blood localization could be due to a reduction in the expression of genes that regulate 
hematopoiesis and erythropoiesis. Therefore, to test this, I measured the level of an important 
blood regulator GATA1 using RT-qPCR.  Relative levels of GATA1 were measured at stage 30 
(35 hpf), a time when the blood islands are forming and GATA1 is vital for proper blood 
development as red blood cell differentiation has begun. Alterations during this time could 
negatively affect both the proliferation and viability of RBCs.  
GATA1 levels in Revel exposed embryos were reduced at stage 30 by a fold change of 
0.33 relative to housekeeping (student t-test, p-value = 0.000715) (Fig 6 A)  
The results from this experiment indicate that Revel exposure reduces GATA1 
expression, most importantly concerning development, at a time when it is critical for initial 
erythropoiesis. 
 
3.7b) Heart development regulators: myocd, dkk1, and tnni3 
I next asked if the reductions in ventricle size and heart rate were due to the effects of 
Revel on the early development of the heart.  To assess this, expression levels of genes integral 
to heart development were measured. RT-qPCR was used to quantify relative expression levels 
of a gene necessary for early development (dkk1), a transcription factor required for 
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cardiomyocyte differentiation (Myocd), and a gene that when transcribed is a protein necessary 
for heart cell contraction (tnni3) in Revel exposed embryos at stage 30 (35 hpf). Stage 30 was 
chosen because at this stage the primary heart tube is beginning to form and soon the looping 
process will begin. Assessing any alterations in the expression of important regulatory genes and 
transcription factors at this state would help to clarify the effect that e-liquid exposure has during 
critical developmental stages.   
Revel exposed embryos showed a reduction in the level of expression of all three genes 
in whole embryos: tnni3 with a fold change of 0.59 (student t-test, p-value = 0.0193), dkk1 had a 
fold change of 0.02 (student t-test, p-value = 2.64 x 10-8), and myocd had a fold change of 0.27 
(student t-test, p-value = 0.0456) (Fig 6 B.) 
The results of these RT-qPCR experiments indicate that Revel e-liquid exposure reduced 
the expression levels of genes important for heart development. 
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4. Discussion 
 
The present work details the effects of an e-liquid containing popular flavors on 
cardiovascular morphology, heart function, and gene expression.  Further, I begin to examine the 
effects this e-liquid has on the development of vasculature and blood. Additionally, it was 
assessed whether the observed defects were due solely to nicotine in combination with common 
inert carriers or instead caused some other substances in the e-liquid solution, perhaps flavoring 
additives. Finally, whether there is something in the aerosolized form that results in different 
phenotypes from the neat preparation was investigated.  
This work demonstrates the potential dangers of ECIG use during development, 
specifically the risks associated with heart defects. Due to the previously established link 
between traditional cigarettes and their negative effect on development and increased risk of 
CHDs, the importance of examining the effects of ECIG exposure on cardiovascular 
development is paramount.  
 
4.1 The effects of e-liquid exposure on cardiovascular development 
 
4.1a) Examining the effects of e-liquid exposure on heart morphology 
Revel exposure resulted in abnormal heart morphology in X. laevis embryos. The heart 
ventricles were smaller, and an aberrant arrangement of the heart was seen. These observations 
are consistent with previous reports of e-liquid and cigarette exposure on zebrafish [14].  X. 
laevis embryos were exposed over a period of heart development so this effect is not likely due 
to non-specific effects at gastrulation. I also determined that genes required in the early induction 
 30 
of the heart and later differentiation of cardiomyocytes were reduced. This is consistent with 
previous studies that have established that e-liquid exposure reduced the expression of 
transcription factors in immature cardiac cells leading to a disruption in the timing of cardiac cell 
differentiation [14]. Therefore, the reduction in ventricle size and abnormal heart morphology 
could be due to a decrease in the number of viable heart cells that differentiate. The proper 
morphology might be dependent on having sufficient tissue. Alternatively, other genes required 
for proper heart looping may be disrupted. While the initial contractions of the cardiac muscle 
play an important role in triggering the looping process, the continued contractions may play a 
supporting role in other factors affecting morphogenesis [51]. Research suggests that the actual 
flow of blood, powered by the developing heart, has a substantial effect on the process of heart 
development, specifically in embryos. While the overall mechanism has not yet been determined, 
certain processes and genes that specifically respond to blood flow continue to be discovered 
[50]. This helps to illustrate the importance of proper conservation of these key processes, which 
seem to be disrupted in those embryos exposed to e-liquid solution in this study.  
Further, the alterations in ventricle morphology may be due to the disruption of early 
cardiac gene expression around the time of heart tube formation. Proper development of the heart 
relies on the synergistic cooperation of several important genes and transcription factors [56]. X. 
laevis embryos exposed to an e-liquid solution had a reduction in the expression of three genes 
that regulate cardiac development. 
The expression of one gene reduced by e-liquid exposure was dkk1. dkk1 expression 
levels in embryos exposed to e-liquid were 98% lower. dkk1 is an important gene that codes for a 
protein that acts to inhibit Wnt signaling during cardiogenesis to ensure proper cardiac cell 
differentiation. Wnt/β-catenin signaling plays a crucial regulatory role in several phases of heart 
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development due to its ability to bind to its receptor, influence gene expression, and in doing so 
activate a multitude of signaling pathways [52]. Throughout development, levels of canonical 
Wnt/β-catenin signaling are tightly regulated and will change depending on the stage. For 
example, while canonical Wnt/β-catenin signaling is first necessary to ensure the formation of 
mesoderm and the proliferation of cardiomyocytes in the heart, it must be lowered to ensure that 
cardiac specification and differentiation are carried out correctly. dkk1 knockdown experiments 
resulted in a reduction in outflow tract, atria, and ventricle size as well as a significant reduction 
in the heart rate [52]. Similarly, embryos that were exposed to Revel e-liquid solution had a 
smaller ventricle size and slower heart rate. Thus, these defects could be attributed to e-liquid 
chemical(s) modulating dkk1 expression.  
Levels of myocd expression were reduced by 73% in embryos exposed to e-
liquid. myocd is expressed exclusively in cardiac and smooth muscle throughout development. 
Myocd plays a role in early heart development, cardiac cell differentiation, as well as smooth 
muscle vasculature differentiation. It does this by being a transcriptional co-activator of serum 
response factor (SRF) that regulates the expression of heart and smooth muscle-specific SRF-
target genes, making it important for the differentiation of smooth muscle and heart development 
[89]. Myocd is an important transcription factor for the initiation of cardiac gene expression as 
overexpression of this gene was shown to cause ectopic expression of multiple heart-related 
genes [55]. Knockdown of myocd in X. laevis resulted in the complete absence of cardiac 
differentiation as well as disruptions in the normal morphogenic movements that take place 
during the formation of the heart tube [53]. This reduction suggests that the e-liquid effects on 
heart morphology could be due to the lack of differentiation of the cardiac muscle. The reduction 
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in myocd expression in embryos exposed to e-liquids could be one reason why the heart is 
smaller and malformed, due to the lack of differentiation of the cardiac muscle. 
Finally, the third gene reduced in my expression analysis of embryos exposed to an e-
liquid was tnni3 whose expression was reduced by 41%. The Tnni3 protein is exclusively 
expressed in cardiac muscle tissues and is a definitive cardiac marker that is commonly used to 
test for altered morphogenesis [54]. tnni3 knockdown studies in mice resulted in death within 
two weeks, due to a decrease in both the size and function of the left ventricle [75]. Considered 
together, the significant decrease in ventricle diameter in embryos exposed to e-liquid could be 
due to the disruption of tnni3 expression. 
Multiple studies have detailed the detrimental effect that both over and underexpression 
of key cardiac genes can have on successful cardiogenesis [52-56]. Revel exposed embryos 
showed lower expression levels of all three of the genes examined and displayed similar 
phenotypes to those described in knockdown experiments. Therefore, the reduction in ventricle 
size and altered heart morphology in embryos exposed to e-liquid may be, at least in part, due to 
the misexpression of such key regulatory genes. 
 
4.1b) Examining the effects of e-liquid exposure on heart function 
In addition to reduced ventricle size heart function, as assessed by ventricular contraction, 
was decreased. Heart rates of Revel exposed embryos showed a significant decrease of 14% 
when compared to that of the control. This is consistent with previous studies that have shown 
that exposure to e-liquid results in significant decreases in zebrafish heart rate [18]. This 
reduction is further demonstrated when analyzing the distribution of the heart rates between the 
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two groups. Measurements showed that 42% of the Revel exposed embryos had heart rates that 
were below 131.6 bpm, lower than any of the control heart rates in this study.  
 One explanation for the reduction in heart rate could be due to the observed decrease in 
ventricle size as well as the malformed heart structure. As structural morphology is altered, it 
stands to reason that the function would undoubtedly be affected. The altered heart rate may be 
due to some insurmountable morphological change. Alternatively, I have shown that Revel 
exposure leads to a reduction in the expression of Tnni3, a cardiac-specific protein that is 
associated with the regulation of heart contraction due to its interaction with the sarcomere [90]. 
Therefore, the irregularities in heart rate may stem from a lack of this critical protein, reducing 
the literal number of viable contractile units within the developing myocardium. Studies in mice 
have shown that as cardiac troponin levels were reduced sarcomeres began to shorten altering 
function [75]. Additionally, Tnni3 must respond directly with varying calcium levels to maintain 
a coordinated rhythm [90]. It is possible that due to the reduced expression levels there is not an 
adequate amount of Tnni3 to interact with the cellular calcium leading to irregular contraction 
patterns and overall rhythm. This is in line with previous knockdown studies that found that there 
was a decreased response to calcium in cardiac troponin depleted in mice [78]. This could 
perhaps also explain why Revel exposed embryo heartbeats would appear to be sporadic 
compared to the even, rolling contractions of the controls. Experiments in this work also show a 
reduction in genes that regulate the differentiation and proliferation of cardiomyocytes, such 
as dkk1. As cardiomyocytes are the cells responsible for generating contractile force, the 
reduction in heart rate may be due to a lack of these cells. It is also possible that e-liquids cause 
disruptions in the physiological environment such as increases in intracellular calcium levels 
leading to irregular rhythms and slowed heart rate. E-liquid, as well as nicotine exposure, has 
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been shown to lead to increases in mitochondrial calcium levels resulting in altered function in 
neural and stem cells [79]. Additionally, neat and aerosolized e-liquid exposure was shown to 
alter intracellular calcium levels independent of nicotine in epithelial cells [88]. E-liquid 
exposure could have similar effects in other tissues as well. Further, this suggests that calcium 
fluctuations are due to chemicals within the e-liquid and not in products formed by combustion. 
Further experiments are needed to examine e-liquid exposure and calcium levels in X. 
laevis cardiac tissues. Another possibility is that Revel exposure disrupts the natural X. 
laevis heart conduction system. Previous studies have shown that X. laevis heart conduction 
responds similarly to that of humans in response to multiple cardiac drugs [71]. Further, in 
humans, it has been noted that malfunctions in the electrical conduction system often present 
themselves alongside malformations in anatomy [71]. It is possible therefore that the disruption 
to heart rate is due to malfunctioning pacemaker cells responsible for the electrical conduction in 
the cardiovascular system, presenting alongside the noted heart malformations. 
More experiments are needed to truly understand why Revel causes defects in heart 
morphology and function. 
      
4.2 Clarifying causative agents for the observed alterations in the X. laevis heart 
  
4.2a) Assessing the effects of nicotine on heart morphology and function 
I first wanted to assess whether the observed reductions in ventricle size and heart rate 
were simply due to nicotine since this chemical is known to alter heart rate in humans [87]. 
Similarly, my goal was to rule out the possibility that the observed cardiac changes might be due 
to a combination of common carrier additives in e-liquid solutions, that might be making 
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nicotine more potent. To test this, embryos were exposed to identical concentrations of a neat 
nicotine solution and an aerosolized mixture of nicotine, propylene glycol (PG), and vegetable 
glycerin (VG), hereafter referred to as “nicotine+PG+VG,” at levels that were identical to those 
in the concentrations of Revel solution used to expose embryos in this study; ventricle diameters 
and heart rates were then recorded. No significant difference was found between any of the 
ventricle diameters between the groups. Similarly, there was no significant difference found in 
the heart rates between any of the groups. There appeared to be no difference in ventricle 
orientation, or shape between any of the groups either. These results suggest that other chemicals 
in e-liquids are responsible for the changes described in this study. This theory is in line with the 
results of previous experiments that have found that popular flavoring additives in e-liquids were 
more toxic than PG and VG alone [77]. Further, studies have shown that the cytotoxic effects of 
ECIGs were not due to nicotine but instead caused by various flavoring chemicals [43].  These 
experiments suggest that at concentrations used in this study, the heart defects in form and 
function in embryos exposed to Revel e-liquid solution are not simply due to nicotine, by itself, 
or complexed with propylene glycol (PG) and vegetable glycerin (VG). Further experiments are 
needed to conclude what specific chemicals are causing these changes, but it is likely due to 
chemicals such as those that are used to add flavoring.  
Chemicals that provide flavor are numerous and include benzyl alcohol, benzaldehyde, 
vanillin [76]. Some flavor additives, such as diacetyl, which lends a creamy flavor to vapor are 
currently on the FDA’s Generally Recognized As Safe list [77]. For this reason, diacetyl may 
seem safe as it may not cause any detriment when digested, however, when inhaled it causes 
bronchitis obliterans [1]. This is partially due to the method of administration, where inhaled 
substances avoid the first-pass metabolism, but also because when aerosolized, these substances 
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undergo chemical changes that convert them into hazardous compounds [58]. Many of these 
chemicals are converted to carcinogens some of which, like benzene, present major danger to 
users as well as those exposed to vapor second hand [60]. Chemicals that lend vapor cinnamon 
(cinnamaldehyde) flavoring have now been shown to be highly toxic and poisonous to D. rerio 
and human stem cells [14].  
 
4.2b) Neat and aerosolized e-liquid exposure results in similar phenotypes 
After concluding that nicotine was not the cause for the altered morphology, I wanted to 
assess whether there was something different in aerosolized e-liquids that was capable of causing 
heart defects. Embryos exposed to either aerosolized or neat Revel appeared very similar 
phenotypically, with a shorter axis, curved bodies, and a reduction in ventricle size. The results 
of these experiments strongly suggest that neat and aerosolized Revel exposure has similar 
effects, at least on heart size and general embryonic morphology. However additional 
experiments and quantification would be necessary. The observed similarities in phenotype 
between preparations lead me to the conclusion that there is something in the actual e-liquid 
itself that goes unchanged when heated, which ultimately results in the alterations. This 
conclusion is in line with previous studies that found no difference in relative toxicity in cells 
between aerosolized and neat e-liquid exposure [77, 82].  This suggests that despite studies 
indicating that propylene glycol (PG) and vegetable glycerin (VG) become harmful substances 
like formaldehyde and acetone when heated [85], these chemicals are not responsible for the 
reduced ventricle size and heart rates in this study. Interestingly, formaldehyde has been 
identified in inhalers used medicinally at similar levels to those found in certain aerosolized e-
liquids [85]. These results suggest that focusing specifically on chemicals that are altered when 
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heated may not hold the key to identifying the compounds that cause these defects in 
morphology.  
One of the difficulties in identifying the chemicals responsible for the adverse effects of 
electronic cigarettes is the high level of variability of their ingredients. In a study that submitted 
122 e-liquids to chemical analysis, 171 unique compounds were detected. 41 of the most 
common compounds detected carried GHS Warning codes, some indicating reproductive and 
organ toxicity [86]. This indicates that the defects observed from e-liquid exposure could be due 
to chemicals known to have damaging health effects that are unaltered during the combustion 
process during vaping. 
 
4.3 Alterations in blood development and distribution as a result of e-liquid exposure                  
In this study, I focus on the distribution of blood and vasculature in the head region of X. 
laevis embryos, as this is a region of interest in our lab. Additional experiments are required to 
fully investigate the effect of e-liquid exposure on developing blood and vasculature in other 
areas. Further, previous studies in our lab found that the presence of blood in the trunk and tail of 
embryos exposed to e-liquid appeared similar to controls [1]. Thus, I did not examine these areas 
deciding to concentrate instead on the head. 
My data and previous studies in our lab, found a change in the localization of blood 
present in the developing X. laevis embryo face using both a histological stain for hemoglobin 
and transgenic embryos carrying a transgene for red blood marker Gata1 at the larval stage. To 
further characterize this, I also measured levels of a gata1 expressed in the head using PCR, 
noting a 42% reduction in expression. Additionally, while blood was visible in the contracting 
ventricle without any staining in almost all of the control embryos, this was not as common in 
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exposed groups. Instead, while contractions were evident, the organ remained translucent and 
without color. Occasionally this would be accompanied by blood that was visible without stain 
pooling around the gut or gills. Gata1 is a transcription factor that codes for two proteins that 
bind DNA and regulate the expression of genes that play an important role in the formation and 
maturation of red blood cells (RBCs) [30]. Therefore, the reduction in blood cells in the head 
might be because the development of the blood itself is altered. Reductions in gata1 expression 
were noted during a critical time when blood islands are forming, and red blood cell 
differentiation has begun. Any scenario that would lower gata1 expression or inactivate all 
together will likely result in one of several deleterious outcomes [4]. First, there may be a lower 
overall amount of red blood cells and platelets present. It is also possible that those that are 
present will have a reduction in function as the Gata1 transcription factors help to regulate the 
maturation of RBCs. Another observed outcome has been a complete lack of these cell types; the 
absence of blood. In a previous study, gata1 knockdown mice all died around the 11-day mark as 
erythrocyte progenitor cells began undergoing apoptosis and large amounts of immature 
megakaryocytes were not able to differentiate into functioning platelets [4]. 
Alternatively, the number of red blood cells could be reduced in the head because of the 
noted alterations in heart size, shape, and function. It is possible that due to this disrupted 
morphology, the blood simply is not able to reach the anterior portion of the embryo due to some 
loss of contractile strength. Studies in human cardiomyocytes have found that electronic cigarette 
exposure resulted in decreases in expression of sarcomeric genes [14]. The sarcomere is the 
contractile unit in muscle tissue. Perhaps it goes beyond the just strength of contractions and 
instead stems from some insurmountable change to the overall structure that lowers cardiac 
output. Previous studies in zebrafish have noted that cigarette smoke exposure resulted in 
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reduced ventricle size and heart rate accompanied by a decrease in stroke volume (the volume of 
blood pumped systemically by the ventricle) [80]. Chemicals in e-liquid vapor might have 
similar effects on cardiac output due to the similarities in ventricle size and heart rate reductions. 
It is also possible that though the heart still beats, it does so in a disorganized way that 
never achieves full recruitment of cardiomyocytes limiting ejection fraction. Further, it could be 
a combination of these two things: a weak contraction that is lacking coordination and regularity.    
Finally, the lack of blood in the face may be due in some part to a lack of blood vessel 
formation. Many of the Flk1 Transgenic embryos exposed to Revel solution had alterations in 
the patterns of the vasculature, with some embryos missing large portions of the observed 
networks in controls.  
The reduction in blood in the head of embryos exposed to e-liquid is likely due in part to 
a reduction in the expression of important transcription factors that regulate blood cell 
development. While further investigation is necessary, it might also be caused by a reduction in 
the amount of blood the malformed heart can pump systemically. 
 
4.4 The effects of e-liquid exposure on vascular development 
To further evaluate the relationship between e-liquid exposure and developing blood 
vessels, a vasculature marker, Flk1, that highlights areas of both vasculogenesis and 
angiogenesis was used. Most of the Flk1 Transgenic embryos that were exposed to Revel 
solution had variances in the patterns of the vasculature, notably with a reduction in the overall 
amount of blood vessels present. This apparent reduction in vasculature could be due to 
alterations in gene expression that play a role in vascular development. Previous studies noted a 
reduction in VEGF, a vascular differentiation marker, in embryos exposed to e-liquid [1]. When 
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addressing the observed lack of blood cells in the head, many embryos exposed to e-liquid were 
missing large portions of the observed vascular networks in controls entirely. This may be due in 
some part to a disruption during development that simply resulted in a lower number of blood 
vessels forming. Cigarette condensate was shown to disrupt vascular patterns and cause 
extensive hemorrhaging in chick embryos [81]. Chemicals in e-liquids could be capable of 
similar disruptive effects. Also, e-liquid exposed groups consistently exhibited edema proximal 
to the heart. The lack of blood in the face may not simply be due to a reduction in viable blood 
cells, but perhaps disrupted networks of vasculature that are “leaky” leading to the observed 
blood pooling near the gut of some embryos. 
Another possible explanation for the apparent reductions in vasculature could be traced 
back to gata1. Again, Gata1 levels were reduced at early developmental stages when angioblasts 
are first beginning to migrate and begin to differentiate into the strands of cells that will go on to 
form tubes and then the primary plexus. Gata1 plays an important role in the expression of an 
angiogenic factor (AGGF1) that promotes endothelial cell proliferation, and when AGGF1 
expression levels are altered results in vascular defects [5]. gata1 knockdown cultures were 
observed to have significant decreases in this angiogenic factor that led to apoptosis of the cell 
layer that lines the interior of blood vessels, and the inhibition of the formation of capillaries 
from endothelial cells [5]. Therefore, the reduction in blood vessels could be due to the alteration 
of genes that play important roles in the formation and maintenance of endothelial cells that will 
eventually become the vasculature. 
Alternatively, the observed changes in the appearance of vascular networks could be due 
to something other than the direct development of the vessels themselves. Revel liquid exposure 
may alter the environment in which the endothelial sheets begin to form tubes by disrupting the 
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Retinoic acid gradient at these stages. Previous studies have shown that disruptions in the 
retinoic pathway can lead to malformation of the major vessels as well as the outflow tract of the 
heart [72].  
The results of this transgenic experiment suggest that there is a disruption and a reduction 
in the vascular network supplying the head. Further experiments need to be done to determine if 
levels of flk1 expression are altered. 
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5. Conclusion 
 
Based on the data collected in this work I am proposing a mechanism of how e-liquids 
exposure could be affecting various aspects of cardiovascular development.  
E-liquid exposure alters regulatory genes and transcription factors during critical 
developmental stages when the earliest cardiac cells are differentiating, and structures are 
forming. These disruptions result in morphological changes that include a reduction in ventricle 
diameter. These changes are not limited to size, but include composition, with alterations in the 
number of functional contractile cells that result in an alteration in heart rate. This early pattern 
of disruption does not rule out the potential for other detrimental effects in later developmental 
patterning and physiology.  
Further, e-liquid exposure reduces the expression of transcription factors that are critical 
for the establishment of the embryonic blood cell lineages and the maintenance of these 
immature blood cells as they mature. This reduction results in a decrease in the number of viable 
cells, and ultimately a lack of blood as progenitor cells are unable to differentiate and avoid 
apoptosis.  
Further, I suggest that e-liquid exposure alters signaling pathways during vasculogenesis 
and angiogenesis that disrupt the formation of functioning capillary networks and instead results 
in a disorganized network of blood vessels that are leaky, resulting in edema and blood pooling 
around the gut and tail. 
The result of these events culminates in defective heart morphology, a reduction in 
cardiac function, and reduced blood flow in the head (Fig 7).  
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These cardiovascular changes help to highlight the dangers of ECIG use during 
pregnancy, as the same disruptions observed in X. laevis could translate to similar defects in 
humans. Due to the use of chemical ingredients suspected to cause damage to the developing 
fetus, certain e-liquids and vapors have the potential to disrupt a myriad of developmental 
processes. As the risk of congenital heart defects increases with prenatal cigarette use, the 
changes in heart form and function in this study indicate that ECIGs could present similar 
hazards. In addition to being dangerous on their own, defects due to ECIGs could become even 
more severe in dual users of both traditional and electronic cigarettes. Further, as we learn more 
about the variety of e-liquid ingredients, there is the potential for interactions with other 
substances such as alcohol that are yet unseen.  
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6. Future Directions 
 
6.1 To determine which components of e-liquid solution cause cardiovascular defects 
 I have shown that electronic cigarette exposure results in a reduction in X. laevis 
ventricle size and heart rate, as well as variability in positioning. The observed heart defects were 
shown not to be caused by nicotine or inert humectants alone. Further studies need to be done to 
try to determine what specific ingredient(s) in Revel e-liquid could be causing the alteration in 
form and function observed. These ingredients could be tested independently as well as in 
synergistic experiments.  
  I have done some preliminary work examining exposure to a common e-liquid flavoring 
component, vanillin, to get a precursory idea of its effect on development. Exposed embryos 
exhibited edema that was so extreme it caused them to have a spherical appearance, impairing 
their ability to move. Also, hearts in exposed embryos were arranged in such a way that seemed 
longer, and “uncoiled”. Heart rates were detected, but not assessed. Due to the elongated heart 
phenotype, it was difficult to judge the efficacy of contractions in most embryos as blood did not 
seem to settle in any specific part of the anatomy before moving to the next. Further, eyes were 
closer together when compared to controls. Shorter axis and body curvatures similar to Revel 
exposed embryos were also detected.  
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6.2 To determine the effects of nicotine and inert carriers on blood and vasculature 
development 
Though nicotine did not appear to cause the observed changes in heart morphology or 
function, I cannot rule out the possibility that it is still altering blood development and 
vasculature in some way. Previous studies have found that nicotine exposure resulted in a 
significant increase in both VEGF mRNA and proteins in pigs. Increases in VEGF have been 
shown to result in increases in angiogenesis as well as increased permeability of forming 
vasculature [73]. Similarly, some studies in zebrafish found that exposure to nicotine in total 
particulate matter from traditional cigarettes results in a decrease in the number of blood vessels 
supplying the brain [74]. It is possible that, despite seeing no difference in cardiac phenotype, 
blood and vasculature were still affected. To assess whether or not nicotine or nicotine+PG+VG 
altered blood development and vasculature, similar PCR and Transgenic experiments to those in 
this study could be conducted.  
 To evaluate changes in vasculature development, levels of VEGF expression in nicotine 
and nicotine+PG+VG exposed embryos could be examined through the use of RT-qPCR at 
multiple stages. For example, stage 22 when VEGF is responsible for the formation of 
hemangioblasts, stage 27 when VEGF influences migration and differentiation of angioblasts, 
and finally stage 46 when principal blood vessels have finished forming.  
  In this work, I showed a decrease in gata1 associated with a reduction in the number of 
blood cells present. To evaluate the effects of nicotine and inert carriers on blood development, 
gata1 levels in these embryos could be investigated as well, at stage 30 when the blood islands 
are forming and stage 40 when the dorsal aorta has formed. Alternatively, to visualize any 
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reductions in blood cells or blood vessels, transgenic lines could be used that would allow these 
structures to be visualized using fluorescent microscopy. 
 
6.3 To better understand the mechanisms by which e-liquid exposure causes cardiovascular 
malformations 
I have shown that e-liquid exposure during development resulted in altered heart 
morphology including a reduction in ventricle size as well as decreases in heart function. 
Embryos exposed to Revel solution continually showed phenotypes in which the heart appeared 
long and “unwound.” Further studies need to be done to determine the specific mechanism that 
leads to the observed malformations. The results of this study suggest a few possibilities. First, e-
liquid exposure may alter the expression of regulatory genes during cardiogenesis that ultimately 
leads to the observed morphological anomalies. Second, e-liquid exposure might alter structures 
that then, in turn, results in some alteration in gene expression similar to those observed in this 
study. These changes could then lead to further morphological change. Similarly, decreases in 
heart function at early stages could lead to disruption in the later stages of development. To 
elucidate this cause and effect relationship the experiments performed in this study would need 
to be extended in scope to include other cardiogenic regulatory genes over many more stages. 
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Figures  
 
Figure 1. Schematic of e-liquid exposure Experimental solutions were added at stage 20-24. Embryos were 
then incubated at 23°C until stage 30 for early PCR experiments or stage 40 where they were washed in 
0.1xMBS. At this point, depending on the specific aim, embryos were either left to mature to stage 45, or 
fixed and dissected for GATA1 RT-PCR. Embryo images: adapted from Nieuwkoop and Faber (1994) Normal 
Table of Xenopus laevis (Daudin). Garland Publishing Inc, New York ISBN 0-8153-1896-0 and Karimi K, 
Fortriede JD, Lotay VS, et al. Xenbase: a genomic, epigenomic and transcriptomic model organism database. 
Nucleic Acids Res. 2018;46(D1):D861–D868. doi:10.1093/nar/gkx936 
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Figure 2. Effects of Revel e-liquid exposure on Heart morphology and function 
(A-D) Representative fluorescent microscope images with Anti-troponin labeling of cardiac protein (green) in 
representative images showing ventral and lateral views in controls. (A, C) Red lines model how ventral 
ventricle measurements were taken. (E-H) Representative light microscope images showing ventral views of 
controls (E, G) and Revel exposed (F, H) embryos. (I) Distribution of ventricle diameter measurements (µm) 
among groups. (J) Ventricle diameters (µm) of experimental groups (n=71, student t-test, p-value = 0.009)  
(K) Relative changes in heart rate (bpm) in control and Revel exposed embryos (n=120, 3 biological 
replicates, Mann-Whitney Rank Sum, P = <0.001)  (L) Distribution of heart rate measurements (bpm) among 
groups. Abbreviations: OT = outflow tract, V = ventricle, G = gut 
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Figure 3. Effect of neat Revel vs aerosolized Revel exposure on X. laevis heart morphology.  
(A-C) Representative light microscope full embryo images displaying typical phenotypic body length and 
body angle of control, neat and aerosolized exposed embryos. (D-F) Representative light microscope images 
showing ventral views of controls (D), neat Revel exposed (E), aerosolized Revel exposed (F) with ventricles 
outlined in red. (G) Distribution of ventricle diameter measurements among groups. 
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Figure 4. Neat nicotine and nicotine+PG+VG effect on heart morphology and function   
(A) Relative heart rates (bpm) in nicotine+PG+VG and neat nicotine compared to control (n=60, 1 replicate, 
Kruskal-Wallis One Way Analysis of Variance on Ranks, p-value = 0.533)  (B) Ventricle diameter 
measurements in control, nicotine+PG+VG, and neat nicotine exposed embryos (n=60, 1 replicate, Kruskal-
Wallis One Way Analysis of Variance on Ranks, p-value = 0.418) (C-E) Representative light microscope 
images showing ventral views of controls (C), nicotine+PG+VG exposed (D), neat nicotine exposed (E) with 
ventricles outlined in red. Abbreviations: OT = outflow tract, V = ventricle 
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Figure 5. o-Dianisidine and Transgenic experiments A-D) Light microscope images of control (A) and 
Revel Exposed (B-D) embryos using an o-Dianisidine stain to detect blood. E-H) Fluorescent microscope 
images of control (E) and Revel (F-H) exposed Transgenic Gata1-GFP embryos used to detect blood. I-L) 
Fluorescent microscope images of control (I) and Revel exposed (J-L) Transgenic FLK-GFP X. laevis 
embryos used to detect vasculature. (M) Relative fold change of gata1 expression as determined by qPCR at 
stage 40 (n=30, 3 replicates, student t-test, p-value = 9.91 x 10-6) 
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Figure 6. E-liquid exposure PCR Experiments   
(A) Relative fold change of GATA1 expression as determined by qPCR at stage 30 (n=40, 1 replicate, student 
t-test, p-value = 0.000715)  (B) Relative fold change of multiple heart gene expression levels at stage 30. 
(N=40, 1 replicate) tnni3 fold change of 0.59 (student t-test, p-value = 0.0193), dkk1 fold change of 0.02 
(student t-test, p-value = 2.64 x 10-8), and myocd fold change of 0.27 (student t-test, p-value = 0.0456) 
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Figure 7. Model of e-liquid Exposure on Cardiovascular Development  
Schematic summary of the proposed model outlining the effects of Revel exposure on cardiovascular 
development in Xenopus laevis. Embryo images adapted from Nieuwkoop and Faber (1994) Normal Table of 
Xenopus laevis (Daudin). Garland Publishing Inc, New York ISBN 0-8153-1896-0 and Karimi K, Fortriede 
JD, Lotay VS, et al. Xenbase: a genomic, epigenomic and transcriptomic model organism database. Nucleic 
Acids Res. 2018;46(D1):D861–D868. doi:10.1093/nar/gkx936 
 
 
 
 
 
 
 54 
 
Table 1. Important Developmental Events in Heart, Vasculature, and Blood Development   
 
 
  
 55 
Literature Cited  
 [1].    Kennedy, Allyson E et al. “E-cigarette aerosol exposure can cause craniofacial defects in 
Xenopus laevis embryos and mammalian neural crest cells.” PloS one vol. 12,9 e0185729. 28 
Sep. 2017, doi:10.1371/journal.pone.0185729 
  
 [2].    Martin, MD, D. J. (Ed.). (2017, April 25). What Is Popcorn Lung? Retrieved from 
WebMD Medical Reference 
 
 [3]. Stroud, Laura. "Tobacco in Pregnancy & Offspring Neurobehavioral Development." Center 
for the Study of Tobacco Products (CSTP) Scientific Meeting. Center for the Study of Tobacco 
Products (CSTP) Scientific Meeting, 21 Mar. 2019, Richmond, Tompkins-McCaw Library, 
MCV Campus. 
 
 [4]. Crispino, John D, and Marshall S Horwitz. "GATA Factor Mutations in Hematologic 
Disease." Blood, American Society of Hematology, 13 Apr. 2017,  
 
 [5]. Fan, Chun, et al. "Novel Roles of GATA1 in Regulation of Angiogenic Factor AGGF1 and 
Endothelial Cell Function." The Journal of Biological Chemistry, American Society for 
Biochemistry and Molecular Biology, 28 Aug. 2009,   
 
 [6]. Commissioner, Office of the. "Results from 2018 National Youth Tobacco Survey Show 
Dramatic Increase in e-Cigarette Use among Youth over Past Year." Results from 2018 National 
Youth Tobacco Survey Show Dramatic Increase in e-Cigarette Use among Youth over Past Year, 
FDA. 
 
 [7]. "Use of Electronic Vapor Products Before, During, and After Pregnancy Among Women 
with a Recent Live Birth - Oklahoma and Texas, 2015 | MMWR." Centers for Disease Control 
and Prevention, Centers for Disease Control and Prevention. 
 
 [8]. Walentek, Peter, and Ian K Quigley. "What We Can Learn from a Tadpole about 
Ciliopathies and Airway Diseases: Using Systems Biology in Xenopus to Study Cilia and 
Mucociliary Epithelia." Genesis (New York, N.Y. : 2000), U.S. National Library of Medicine, 
Jan. 2017. 
 
 [9]. Islas-Flores, Hariz, et al. "Evaluation of Teratogenicity of Pharmaceuticals Using FETAX." 
Methods in Molecular Biology (Clifton, N.J.), U.S. National Library of Medicine, 2018. 
 
 56 
 [10]. Bantle, J A, et al. "Further Validation of FETAX: Evaluation of the Developmental 
Toxicity of Five Known Mammalian Teratogens and Non-Teratogens." Drug and Chemical 
Toxicology, U.S. National Library of Medicine, 1990. 
  
[11]. Behar, Rachel Z., et al. “Analytical and Toxicological Evaluation of Flavor Chemicals in 
Electronic Cigarette Refill Fluids.” Nature News, Nature Publishing Group, 29 May 2018, 
https://www.nature.com/articles/s41598-018-25575-6. 
 
 [12]. Honein, Margaret & Devine, Owen & Grosse, Scott & Reefhuis, Jennita. (2014). 
Prevention of Orofacial Clefts Caused by Smoking: Implications of the Surgeon General's 
Report. Birth Defects Research Part A: Clinical and Molecular Teratology. 100. 
10.1002/bdra.23274.  
 
 [13]. Cristina Gonçalves Leite, Isabel & Koifman, Sergio. (2009). Oral clefts, consanguinity, 
parental tobacco and alcohol use: A case-control study in Rio de Janeiro, Brazil. Brazilian oral 
research. 23. 31-7. 10.1590/S1806-83242009000100006.  
 
 [14]. Palpant NJ, Hofsteen P, Pabon L, Reinecke H, Murry CE (2015) Cardiac Development in 
Zebrafish and Human Embryonic Stem Cells Is Inhibited by Exposure to Tobacco Cigarettes and 
E-Cigarettes. PLoS ONE 10(5): e0126259. https://doi.org/10.1371/journal.pone.0126259 
 
 [15]. Shi, Huilin, et al. “The Effect of Electronic-Cigarette Vaping on Cardiac Function and 
Angiogenesis in Mice.” Nature News, Nature Publishing Group, 11 Mar. 2019, 
https://www.nature.com/articles/s41598-019-40847-5. 
 
 [16]. Farsalinos, K.E.; Romagna, G.; Allifranchini, E.; Ripamonti, E.; Bocchietto, E.; Todeschi, 
S.; Tsiapras, D.; Kyrzopoulos, S.; Voudris, V. Comparison of the Cytotoxic Potential of 
Cigarette Smoke and Electronic Cigarette Vapour Extract on Cultured Myocardial Cells. Int. J. 
Environ. Res. Public Health 2013, 10, 5146-5162. 
 
 [17]. R.Orzabalaǂ, Marcus, et al. “Chronic Exposure to e-Cig Aerosols during Early 
Development Causes Vascular Dysfunction and Offspring Growth Deficits.” Translational 
Research, Mosby, 7 Jan. 2019, 
https://www.sciencedirect.com/science/article/pii/S1931524419300027?via=ihub. 
 
 [18]. Massarsky, Andrey et al. “Teratogenic, bioenergetic, and behavioral effects of exposure to 
total particulate matter on early development of zebrafish (Danio rerio) are not mimicked by 
nicotine.” Neurotoxicology and teratology vol. 51 (2015): 77-88. doi:10.1016/j.ntt.2015.09.006 
 
 57 
 [19]. Lauterstein, Dana E et al. “Frontal Cortex Transcriptome Analysis of Mice Exposed to 
Electronic Cigarettes During Early Life Stages.” International journal of environmental research 
and public health vol. 13,4 417. 12 Apr. 2016, doi:10.3390/ijerph13040417 
 
 [20]. McGrath-Morrow SA, Hayashi M, Aherrera A, Lopez A, Malinina A, Collaco JM, et al. 
(2015) The Effects of Electronic Cigarette Emissions on Systemic Cotinine Levels, Weight and 
Postnatal Lung Growth in Neonatal Mice. PLoS ONE 10(2): e0118344. 
https://doi.org/10.1371/journal.pone.0118344 
 
 [21]. Zhao, Lijuan, et al. “Parental Smoking and the Risk of Congenital Heart Defects in 
Offspring: An Updated Meta-Analysis of Observational Studies - Lijuan Zhao, Lizhang Chen, 
Tubao Yang, Lesan Wang, Tingting Wang, Senmao Zhang, Letao Chen, Ziwei Ye, Zan Zheng, 
Jiabi Qin.” SAGE Journals, https://journals.sagepub.com/doi/10.1177/2047487319831367. 
 [22]. “Data and Statistics on Congenital Heart Defects | CDC.” Centers for Disease Control and 
Prevention, Centers for Disease Control and Prevention, 
https://www.cdc.gov/ncbddd/heartdefects/data.html. 
 [23]. Dongyu Zhang, Hao Cui, Long Zhang, Yanjie Huang, Jun Zhu & Xiaohong Li (2017) Is 
maternal smoking during pregnancy associated with an increased risk of congenital heart defects 
among offspring? A systematic review and meta-analysis of observational studies, The Journal 
of Maternal-Fetal & Neonatal Medicine, 30:6, 645-657, DOI: 10.1080/14767058.2016.1183640 
 [24]. Lee, Laura J., and Philip J. Lupo. “Maternal Smoking During Pregnancy and the Risk of 
Congenital Heart Defects in Offspring: A Systematic Review and Metaanalysis.” SpringerLink, 
Springer-Verlag, 12 Aug. 2012, https://link.springer.com/article/10.1007/s00246-012-0470-x. 
 [25]. Wagner, Nicholas J et al. “Prevalence and Perceptions of Electronic Cigarette Use during 
Pregnancy.” Maternal and child health journal vol. 21,8 (2017): 1655-1661. 
doi:10.1007/s10995-016-2257-9 
 
 [26]. Carlsenab, Karin C.Lødrup. “The Toxicity of E-Cigarettes and Children's Respiratory 
Health.” Paediatric Respiratory Reviews, W.B. Saunders, 10 Feb. 2018, 
https://www.sciencedirect.com/science/article/pii/S1526054218300046. 
 
 [27]. Hempel, Annemarie, and Michael Kühl. “A Matter of the Heart: The African Clawed Frog 
Xenopus as a Model for Studying Vertebrate Cardiogenesis and Congenital Heart Defects.” 
 58 
Journal of cardiovascular development and disease vol. 3,2 21. 4 Jun. 2016, 
doi:10.3390/jcdd3020021 
 
 [28] O. Cleaver, P. A. Krieg, VEGF mediates angioblast migration during development of the 
dorsal aorta in Xenopus. Development 125, 3905–3914 (1998). 
 
 [29]. Ciau-Uitz, Aldo, et al. “Developmental Hematopoiesis: Ontogeny, Genetic Programming 
and Conservation.” Experimental Hematology, Elsevier, 17 June 2014, 
https://www.sciencedirect.com/science/article/pii/S0301472X14002331. 
 
 [30]. Zon, L I, et al. “Expression of GATA-Binding Proteins during Embryonic Development in 
Xenopus Laevis.” Proceedings of the National Academy of Sciences of the United States of 
America, U.S. National Library of Medicine, 1 Dec. 1991, 
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC52986/. 
 
 [31]. Andrey Massarsky, Ayham Abdel, Lilah Glazer, Edward D. Levin, and Richard T. Di 
Giulio.Zebrafish.Jun 2017.ahead of print http://doi.org/10.1089/zeb.2016.1400 
 
 [32]. Yamaguchi, T.P., et al. “Flk-1, an Flt-Related Receptor Tyrosine Kinase Is an Early 
Marker for Endothelial Cell Precursors.” Development, The Company of Biologists Ltd, 1 June 
1993, https://dev.biologists.org/content/118/2/489.long. 
 
 [33]. Kolker, S J et al. “Confocal imaging of early heart development in Xenopus laevis.” 
Developmental biology vol. 218,1 (2000): 64-73. doi:10.1006/dbio.1999.9558 
 
 [34]. alas2 Summary [Species: Xenopus Laevis and Xenopus Tropicalis] - Xenbase Gene 
Catalog, http://www.xenbase.org/gene/showgene.do?method=display&geneId=XB-GENE-
487573. 
 
 [35]. Database, Gene. “TUBB1 Gene(Protein Coding).” GeneCards, 
https://www.genecards.org/cgi-bin/carddisp.pl?gene=TUBB1. 
 
 [36]. Database, Gene. “RHD Gene(Protein Coding).” GeneCards, 
https://www.genecards.org/cgi-bin/carddisp.pl?gene=RHD. 
 
 [37]. Database, Gene. “THBD Gene(Protein Coding).” GeneCards, 
https://www.genecards.org/cgi-bin/carddisp.pl?gene=THBD#function. 
 
 59 
[38] Bantle, J.A., et al., Further validation of FETAX: evaluation of the developmental toxicity 
of five known mammalian teratogens and non-teratogens. Drug Chem Toxicol, 1990. 13(4): p. 
267-82. 
 
[39] Fort, D.J., et al., Assessing the predictive validity of frog embryo teratogenesis assay-
Xenopus (FETAX). Teratog Carcinog Mutagen, 2000. 20(2): p. 87-98.  
 
[40] Fuchigami, T., T. Matsuzaki, and S. Ihara, Possible roles of ENaC and Cl(-) channel in 
wound closure in Xenopus laevis embryos. Zoolog Sci, 2011. 28(10): p. 703-11. 
[41] Dubaissi, E., et al., A secretory cell type develops alongside multiciliated cells, ionocytes 
and goblet cells, and provides a protective, anti-infective function in the frog embryonic 
mucociliary epidermis. Development, 2014. 141(7): p. 1514-25.  
[42] Detrich, H W, et al. “Intraembryonic Hematopoietic Cell Migration during Vertebrate 
Development.” Proceedings of the National Academy of Sciences of the United States of 
America, U.S. National Library of Medicine, 7 Nov. 1995, 
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC40682/. 
[43] Bahl, Vasundhra, et al. “Comparison of Electronic Cigarette Refill Fluid Cytotoxicity Using 
Embryonic and Adult Models.” Reproductive Toxicology, Pergamon, 20 Aug. 2012, 
https://www.sciencedirect.com/science/article/pii/S0890623812002833. 
[44] Tamori, Y, and M Wakahara. “Conversion of Red Blood Cells (RBCs) from the Larval to 
the Adult Type during Metamorphosis in Xenopus: Specific Removal of Mature Larval-Type 
RBCs by Apoptosis.” The International Journal of Developmental Biology, U.S. National 
Library of Medicine, June 2000, https://www.ncbi.nlm.nih.gov/pubmed/10949046. 
 
[45]J.Mohuna1, Timothy, et al. “The Morphology of Heart Development in Xenopus Laevis.” 
Developmental Biology, Academic Press, 25 May 2002, 
https://www.sciencedirect.com/science/article/pii/S0012160699995593. 
 
[46] Breckenridgea, Ross, and Tim JMohunb. “A Role for BMP Signalling in Heart Looping 
Morphogenesis in Xenopus.” Developmental Biology, Academic Press, 25 May 2002, 
https://www.sciencedirect.com/science/article/pii/S0012160601901642. 
 
[47] “Outbreak of Lung Injury Associated with E-Cigarette Use, or Vaping.” Centers for Disease 
Control and Prevention, Centers for Disease Control and Prevention, 
https://www.cdc.gov/tobacco/basic_information/e-cigarettes/severe-lung-disease.html. 
 
 60 
[48] Xu Y, Guo Y, Liu K, Liu Z, Wang X (2016) E-Cigarette Awareness, Use, and Harm 
Perception among Adults: A Meta-Analysis of Observational Studies. PLoS ONE 11(11): 
e0165938. https://doi.org/10.1371/journal.pone.0165938 
 
[49] Smith, S. J., Towers, N., Demetriou, K., & Mohun, T. J. (2020). Defective heart chamber 
growth and myofibrillogenesis after knockout of adprhl1 gene function by targeted disruption of 
the ancestral catalytic active site. doi: 10.1101/2020.02.13.947424 
 
[50] Boselli, F., Freund, J. B., & Vermot, J. (2015). Blood flow mechanics in cardiovascular 
development. Cellular and Molecular Life Sciences, 72(13), 2545–2559. doi: 10.1007/s00018-
015-1885-3 
 
[51] Sidhwani, P., & Yelon, D. (2019). Fluid forces shape the embryonic heart: Insights from 
zebrafish. Current Topics in Developmental Biology Organ Development, 395–416. doi: 
10.1016/bs.ctdb.2018.12.009 
 
[52] Guo, Y., Dorn, T., Kühl, S. J., Linnemann, A., Rothe, M., Pfister, A. S., … Kühl, M. (2019). 
The Wnt inhibitor Dkk1 is required for maintaining the normal cardiac differentiation program in 
Xenopus laevis. Developmental Biology, 449(1), 1–13. doi: 10.1016/j.ydbio.2019.02.009 
 
[53] Small, E. M. (2005). Myocardin is sufficient and necessary for cardiac gene expression in 
Xenopus. Development, 132(5), 987–997. doi: 10.1242/dev.01684 
 
[54] Drysdale, T. A., Tonissen, K. F., Patterson, K. D., Crawford, M. J., & Krieg, P. A. (1994). 
Cardiac Troponin I Is a Heart-Specific Marker in the Xenopus Embryo: Expression during 
Abnormal Heart Morphogenesis. Developmental Biology, 165(2), 432–441. doi: 
10.1006/dbio.1994.1265 
 
[55] Chen, Jian-Fu, et al. “Myocardin Marks the Earliest Cardiac Gene Expression and Plays an 
Important Role in Heart Development.” The Anatomical Record: Advances in Integrative 
Anatomy and Evolutionary Biology, vol. 291, no. 10, 2008, pp. 1200–1211., 
doi:10.1002/ar.20756. 
 
[56] Gessert, Susanne, and Michael Kühl. “Comparative Gene Expression Analysis and Fate 
Mapping Studies Suggest an Early Segregation of Cardiogenic Lineages in Xenopus Laevis.” 
Developmental Biology, vol. 334, no. 2, 2009, pp. 395–408., doi:10.1016/j.ydbio.2009.07.037. 
 
[57] Weiss, M J, et al. “Erythroid-Cell-Specific Properties of Transcription Factor GATA-1 
Revealed by Phenotypic Rescue of a Gene-Targeted Cell Line.” Molecular and Cellular Biology, 
vol. 17, no. 3, 1997, pp. 1642–1651., doi:10.1128/mcb.17.3.1642. 
 61 
 
[58] Tierney PA, Karpinski CD, Brown JE, Luo W, Pankow JF. Flavour chemicals in electronic 
cigarette fluids. Tob Control. 2016;25(e1):e10–5. pmid:25877377; PubMed Central PMCID: 
PMCPMC4853541. 
 
[59] Brass DM, Gwinn WM, Valente AM, Kelly FL, Brinkley CD, Nagler AE, et al. The 
Diacetyl-exposed Human Airway Epithelial Secretome: New Insights Into Flavoring Induced 
Airways Disease. Am J Respir Cell Mol Biol. 2017. pmid:28248570. 
 
[60] Pankow JF, Kim K, McWhirter KJ, Luo W, Escobedo JO, Strongin RM, et al. Benzene 
formation in electronic cigarettes. PLoS One. 2017;12(3):e0173055. pmid:28273096; PubMed 
Central PMCID: PMCPMC5342216. 
 
[61] Lamalice, Laurent, et al. “Endothelial Cell Migration During Angiogenesis.” Circulation 
Research, vol. 100, no. 6, 2007, pp. 782–794., doi:10.1161/01.res.0000259593.07661.1e. 
 
[62] Charpentier MS, Tandon P, Trincot CE, Koutleva EK, Conlon FL (2015) A Distinct 
Mechanism of Vascular Lumen Formation in Xenopus Requires EGFL7. PLoS ONE 10(2): 
e0116086. doi:10.1371/ journal.pone.0116086 
 
[63] Levine, Ariel J, et al. “Fluorescent Labeling of Endothelial Cells Allows in Vivo, 
Continuous Characterization of the Vascular Development of Xenopus Laevis.” Developmental 
Biology, vol. 254, no. 1, 2003, pp. 50–67., doi:10.1016/s0012-1606(02)00029-5. 
 
[64] Ciau-Uitz, Aldo, et al. “Genetic Control of Hematopoietic Development in Xenopus and 
Zebrafish.” The International Journal of Developmental Biology, vol. 54, no. 6-7, 2010, pp. 
1139–1149., doi:10.1387/ijdb.093055ac. 
 62 
 
[65] Mead, P.E., Deconinck, A.E., Huber, T.L., Orkin, S.H., and Zon, L.I. (2001). Primitive 
erythropoiesis in the Xenopus embryo: the synergistic role of LMO-2, SCL and GATA-binding 
proteins. Development 128, 2301-2308.  
 
[66] K.E Elagib, F.K Racke, M Mogass, R Khetawat, L.L Delehanty, A.N Goldfarb RUNX1 and 
GATA-1 coexpression and cooperation in megakaryocytic differentiation Blood, 101 (2003), pp. 
4333-4341 
 
[67] Trainor, Cecelia D., et al. “GATA-1 Associates with and Inhibits p53.” Blood, vol. 114, no. 
1, Feb. 2009, pp. 165–173., doi:10.1182/blood-2008-10-180489. 
 
[68] Zon, Leonard I. Hematopoiesis: a Developmental Approach. Oxford University Press, 2001. 
 
[69] Godin, Isabelle, and Ana Cumano. Hematopoietic Stem Cell Development. Landes 
Bioscience/Eurekah.com, 2006. 
 
[70] Ciau-Uitz, A., Walmsley, M., & Patient, R. (2000). Distinct Origins of Adult and 
Embryonic Blood in Xenopus. Cell, 102(6), 787–796. doi: 10.1016/s0092-8674(00)00067-2 
 
[71] Bartlett, Heather L., et al. “Characterization of Embryonic Cardiac Pacemaker and 
Atrioventricular Conduction Physiology in Xenopus Laevis Using Noninvasive Imaging.” 
American Journal of Physiology-Heart and Circulatory Physiology, vol. 286, no. 6, 2004, 
doi:10.1152/ajpheart.00807.2003. 
 
[72] Roberts, C. Regulating Retinoic Acid Availability during Development and Regeneration: 
The Role of the CYP26 Enzymes. J. Dev. Biol. 2020, 8, 6. 
 
[73] Conklin, Brian S., et al. “Nicotine and Cotinine Up-Regulate Vascular Endothelial Growth 
Factor Expression in Endothelial Cells.” The American Journal of Pathology, vol. 160, no. 2, 
2002, pp. 413–418., doi:10.1016/s0002-9440(10)64859-6. 
 
[74]Massarsky, Andrey, et al. “Total Particulate Matter from Cigarette Smoke Disrupts Vascular 
Development in Zebrafish Brain (Danio Rerio).” Toxicology and Applied Pharmacology, vol. 
339, 2018, pp. 85–96., doi:10.1016/j.taap.2017.12.003. 
 
 63 
[75] Liu J., Du J., Zhang C., Walker J.W., Huang X.P. “Progressive troponin I loss impaires 
cardiac relaxation and causes heart failure in mice,” Am J Physiol Heart Circ Physiol. 
2007;293:H1273–H1281. doi: 10.1152/ajpheart.01379.2006. 
 
[76] Czoli, C.D., Goniewicz, M.L., Palumbo, M. et al. Identification of flavouring chemicals and 
potential toxicants in e-cigarette products in Ontario, Canada. Can J Public Health 110, 542–550 
(2019). 
 
[77] Sassano, M. Flori, et al. “Evaluation of e-Liquid Toxicity Using an Open-Source High-
Throughput Screening Assay.” PLOS Biology, vol. 16, no. 3, 2018, 
doi:10.1371/journal.pbio.2003904. 
 
[78] Huang, Xupei, et al. “Cardiac Troponin I Gene Knockout.” Circulation Research, vol. 84, 
no. 1, 1999, doi:10.1161/01.res.84.1.1. 
 
[79] Zahedi A., Phandthong R., Chaili A., Leung S., Omaiye E., Talbot P. A Mitochondrial 
Stress Response in Neural Stem Cells Exposed to Electronic Cigarettes. iScience. 2019;16:250–
269. doi: 10.1016/j.isci.2019.05.034. 
 
[80] Folkesson, Maggie, et al. “Differences in Cardiovascular Toxicities Associated with 
Cigarette Smoking and Snuff Use Revealed Using Novel Zebrafish Models.” Biology Open, vol. 
5, no. 7, 2016, pp. 970–978., doi:10.1242/bio.018812. 
 
[81] Ejaz, S., Ejaz, A., Sohail, A., & Lim, C. W. (2010). Vascular and Morphogenetic 
Abnormalities Associated with Exposure of Cigarette Smoke Condensate during Chicken and 
Murine Embryogenesis. Biomedical and Environmental Sciences, 23(4), 305–311. doi: 
10.1016/s0895-3988(10)60068-2 
 
[82] Rowell, Temperance R., et al. “Flavored e-Cigarette Liquids Reduce Proliferation and 
Viability in the CALU3 Airway Epithelial Cell Line.” American Journal of Physiology-Lung 
Cellular and Molecular Physiology, vol. 313, no. 1, Jan. 2017, doi:10.1152/ajplung.00392.2016. 
 
[83] Sive H, Grainger R, Harland R. Early Development of Xenopus laevis: a laboratory manual: 
Cold Spring Harbor Laboratory Press; 2000. 
 
[84] Nieuwkoop, P. D. and J. Faber (1967). Normal Table of Xenopus Laevis (Daudin). New 
York, Garland Publishing Inc. 
 
 64 
[85] Goniewicz, Maciej Lukasz, et al. “Levels of Selected Carcinogens and Toxicants in Vapour 
from Electronic Cigarettes.” Tobacco Control, vol. 23, no. 2, June 2013, pp. 133–139., 
doi:10.1136/tobaccocontrol-2012-050859. 
 
[86] Girvalaki, Charis, et al. “Composition and Chemical Health Hazards of the Most Common 
Electronic Cigarette Liquids in Nine European Countries.” Inhalation Toxicology, vol. 30, no. 9-
10, 2018, pp. 361–369., doi:10.1080/08958378.2018.1527879. 
 
[87] Benowitz, Neal L., and Andrea D. Burbank. “Cardiovascular Toxicity of Nicotine: 
Implications for Electronic Cigarette Use.” Trends in Cardiovascular Medicine, vol. 26, no. 6, 
2016, pp. 515–523., doi:10.1016/j.tcm.2016.03.001. 
 
[88] Rowell, T. R., Keating, J. E., Zorn, B. T., Glish, G. L., Shears, S. B., & Tarran, R. (2020). 
Flavored e-liquids increase cytoplasmic Ca2 levels in airway epithelia. American Journal of 
Physiology-Lung Cellular and Molecular Physiology, 318(2). doi: 10.1152/ajplung.00123.2019 
 
[89] Database, Gene. “MYOCD Gene (Protein Coding).” GeneCards, www.genecards.org/cgi-
bin/carddisp.pl?gene=MYOCD. 
 
[90] “TNNI3 Gene - Genetics Home Reference - NIH.” U.S. National Library of Medicine, 
National Institutes of Health, ghr.nlm.nih.gov/gene/TNNI3. 
  
 65 
VITA 
 
James Edward Black III (Jeb) was born on August 3rd, 1985 in Norfolk, Virginia. He 
received his Bachelor of Science in Biology from the College of Humanities and Sciences at 
Virginia Commonwealth University in 2018 after over a decade of writing, recording, and 
playing music across the United States and abroad. After receiving his Master of Science (M.S.) 
in Biology, he will be attending Eastern Virginia Medical School as a student in the M.D. 
program. Anything is possible. 
  
 
     
    
   
 
 
